关键数据
3.470今开
3.530最高
28.63K成交量
1.84市盈率 TTM
2.10市盈率动
0.600股息TTM
0.05%换手率
3.435昨收
3.470最低
77.69K成交额
2.19市盈率静
-0.34市净率
17.03%股息率 TTM
10.41%ROA
15.55052周最高
0.51量比
95.40M净利润
59.21M总股本
1.9092每股收益TTM
1.09Beta
--ROE
8.47052周最低
1.74%振幅
56.45%毛利率
208.56M总市值
-0.48回报/风险
3.29%风险率
操作建议
Embecta Corp当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名56/199位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价10.00。中期看,股价处于下降通道。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
Embecta Corp新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Embecta Corp简介
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
公司代码EMBC
公司Embecta Corp
CEOKurdikar (Devdatt)
网址https://www.embecta.com/
公司股东
常见问题
Embecta Corp(EMBC)的当前股价是多少?
Embecta Corp(EMBC)的当前股价是 3.43。
Embecta Corp股票的52周最高点是多少?
Embecta Corp股票的52周最高点是15.55。
Embecta Corp股票的52周最低点是多少?
Embecta Corp股票的52周最低点是8.47。
现在Embecta Corp(EMBC)的股票是买入、持有还是卖出?
根据分析师评级,Embecta Corp(EMBC)的总体评级为signal_hold,目标价格为10.00。
Embecta Corp(EMBC)股票的每股收益(EPS TTM)是多少
Embecta Corp(EMBC)股票的每股收益(EPS TTM)是1.64。